These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22528594)

  • 21. Efficacy and safety of short-term dual antiplatelet therapy (≤6 months) after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Misumida N; Abo-Aly M; Kim SM; Ogunbayo GO; Abdel-Latif A; Ziada KM
    Clin Cardiol; 2018 Nov; 41(11):1455-1462. PubMed ID: 30225978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of unfractionated heparin plus glycoprotein IIb/IIIa inhibitors during revascularization for an acute coronary syndrome: a meta-analysis of randomized trials performed with stents and thienopyridines.
    Winchester DE; Brearley WD; Wen X; Park KE; Bavry AA
    Clin Cardiol; 2012 Feb; 35(2):93-100. PubMed ID: 22028212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy.
    Pride YB; Tung P; Mohanavelu S; Zorkun C; Wiviott SD; Antman EM; Giugliano R; Braunwald E; Gibson CM;
    JACC Cardiovasc Interv; 2010 Aug; 3(8):806-11. PubMed ID: 20723851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet therapy and percutaneous coronary intervention in patients with acute coronary syndrome and thrombocytopenia.
    Yusuf SW; Iliescu C; Bathina JD; Daher IN; Durand JB
    Tex Heart Inst J; 2010; 37(3):336-40. PubMed ID: 20548817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study.
    Bhatt DL; Fox K; Harrington RA; Leiter LA; Mehta SR; Simon T; Andersson M; Himmelmann A; Ridderstråle W; Held C; Steg PG;
    Clin Cardiol; 2019 May; 42(5):498-505. PubMed ID: 30788847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy.
    Mehta SR; Bassand JP; Chrolavicius S; Diaz R; Fox KA; Granger CB; Jolly S; Rupprecht HJ; Widimsky P; Yusuf S;
    Am Heart J; 2008 Dec; 156(6):1080-1088.e1. PubMed ID: 19033002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet therapy: cangrelor for ACS-lessons from the CHAMPION trials.
    Faxon DP
    Nat Rev Cardiol; 2010 Mar; 7(3):124-5. PubMed ID: 20179718
    [No Abstract]   [Full Text] [Related]  

  • 29. Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Pham SV; Pham PC; Pham PM; Miller JM; Pham PT; Pham PA
    Drug Des Devel Ther; 2010 Sep; 4():203-20. PubMed ID: 20856846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ticagrelor: an investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome.
    Abergel E; Nikolsky E
    Vasc Health Risk Manag; 2010 Oct; 6():963-77. PubMed ID: 21057581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risks and benefits of triple oral anti-thrombotic therapies after acute coronary syndromes and percutaneous coronary intervention.
    Alfredsson J; Roe MT
    Drug Saf; 2015 May; 38(5):481-91. PubMed ID: 25829216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of prasugrel for the secondary prevention of atherothrombosis.
    Spinler SA; Rees C
    J Manag Care Pharm; 2009 Jun; 15(5):383-95. PubMed ID: 19496635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial.
    Ray KK; Nicholls SJ; Ginsberg HD; Johansson JO; Kalantar-Zadeh K; Kulikowski E; Toth PP; Wong N; Cummings JL; Sweeney M; Schwartz GG
    Am Heart J; 2019 Nov; 217():72-83. PubMed ID: 31520897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet and anticoagulant agents: key differences in mechanisms of action, clinical application, and therapeutic benefit in patients with non-ST-segment-elevation acute coronary syndromes.
    Jennings LK; Saucedo JF
    Curr Opin Cardiol; 2008 Jul; 23(4):302-8. PubMed ID: 18520712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance.
    Bonvini RF; Reny JL; Mach F; Zeller T; Fontana P
    Curr Vasc Pharmacol; 2009 Apr; 7(2):198-208. PubMed ID: 19356003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ST-segment resolution and prognosis after facilitated versus primary percutaneous coronary intervention in acute myocardial infarction: a meta-analysis.
    Eitel I; Franke A; Schuler G; Thiele H
    Clin Res Cardiol; 2010 Jan; 99(1):1-11. PubMed ID: 19727894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [IMPACT OF ATORVASTATIN AND ROSUVASTATIN ON RESIDUAL ON-CLOPIDOGREL TREATMENT PLATELET REACTIVITY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND TYPE 2 DIABETES MELLITUS AFTER ACUTE CORONARY SYNDROME].
    Ovrakh T; Serik S; Kochubiei O
    Georgian Med News; 2017 Apr; (265):7-14. PubMed ID: 28574378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Multidisciplinary management of patients with acute coronary syndrome and diabetes mellitus: from antithrombotic therapy to treatment of hyperglycemia].
    Rossini R; Cimino A; De Servi S; Grieco N; Lettieri C; Mafrici A; Musumeci G; Perseghin G; Sponzilli C; Trevisan R; Visconti LO; ; ;
    G Ital Cardiol (Rome); 2014 Jun; 15(6):378-92. PubMed ID: 25072424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project.
    Zhao G; Zhou M; Ma C; Huo Y; Smith SC; Fonarow GC; Ge J; Han Y; Liu J; Hao Y; Liu J; Wang X; Taubert KA; Morgan L; Zhao D; Nie S;
    J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29602767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reperfusion strategies in ST-segment elevation myocardial infarction.
    Stiermaier T; Desch S; Schuler G; Thiele H; Eitel I
    Minerva Med; 2013 Aug; 104(4):391-411. PubMed ID: 24008602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.